Jane Street Group, LLC Infla Rx N.V. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.47 - $2.03 $68,377 - $94,425	46,515 New	46,515 $71,000
Q2 2023 Aug 14, 2023	BUY	$2.05 - $6.1 $71,526 - $212,835	34,891 New	34,891 $155,000
Q4 2018 Feb 15, 2019	SELL	$23.33 - $36.37 $189,019 - $294,669	-8,102 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$29.34 - $35.0 $237,712 - $283,570	8,102 New	8,102 $278,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.